3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
20
Carcinoma, Renal Cell
10
Neuroendocrine Tumors
7
Neoplasm Metastasis
7
Recurrence
4
Tuberous Sclerosis
3
Triple Negative Breast Neoplasms
3
Neoplasms
3
Kidney Neoplasms
3
Endometrial Neoplasms
3
von Hippel-Lindau Disease
2
Skin Neoplasms
2
Sarcoma
2
Meningioma
2
Glioma
2
Gastro-enteropancreatic neuroendocrine tumor
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Hepatocellular
2
Adenoma, Islet Cell
2
Waldenstrom Macroglobulinemia
1
Vascular Malformations
1
Unilateral Breast Neoplasms
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thymus Neoplasms
1
Seizures
1
Sarcoma, Kaposi
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Interventions
Rituximab
45
Cyclophosphamide
38
ibrutinib
22
fludarabine
22
acalabrutinib
21
venetoclax
20
zanubrutinib
17
Lenalidomide
17
Bendamustine Hydrochloride
17
obinutuzumab
16
fludarabine phosphate
14
Magnetic Resonance Spectroscopy
14
Cytarabine
14
Specimen Handling
13
CT-P10
13
pirtobrutinib
12
Biopsy
12
glofitamab
10
Etoposide
10
Whole-Body Irradiation
9
Vincristine
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Melphalan
7
Doxorubicin
7
brexucabtagene autoleucel
6
Cyclosporine
6
orelabrutinib
5
Methotrexate
5
Immunotherapy, Adoptive
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Everolimus
×
1 year
×
Clear all
No trials found.